Literature DB >> 30274750

Incremental diagnostic and prognostic value of the QRS-T angle, a 12-lead ECG marker quantifying heterogeneity of depolarization and repolarization, in patients with suspected non-ST-elevation myocardial infarction.

Ivo Strebel1, Raphael Twerenbold2, Desiree Wussler1, Jasper Boeddinghaus1, Thomas Nestelberger1, Jeanne du Fay de Lavallaz1, Roger Abächerli3, Patrick Maechler4, Diego Mannhart1, Nikola Kozhuharov1, Maria Rubini Giménez5, Karin Wildi1, Lorraine Sazgary1, Zaid Sabti1, Christian Puelacher1, Patrick Badertscher1, Dagmar I Keller6, Òscar Miró7, Carolina Fuenzalida7, Sofia Calderón7, F Javier Martin-Sanchez8, Sergio Lopez Iglesias8, Stefan Osswald1, Christian Mueller1, Tobias Reichlin9.   

Abstract

BACKGROUND: The value of the 12-lead ECG in the diagnosis of non-ST-elevation myocardial infarction (NSTEMI) is limited due to insufficient sensitivity and specificity of standard ECG criteria. The QRS-T angle reflects depolarization-repolarization heterogeneity and might assist in detecting patients with a NSTEMI (diagnosis) as well as predicting patients with an increased mortality risk (prognosis).
METHODS: We prospectively enrolled 2705 consecutive patients with symptoms suggestive of NSTEMI. The QRS-T angle was automatically derived from the standard 10 s 12-lead ECG recorded at presentation to the ED. Patients were followed up for all-cause mortality for 2 years.
RESULTS: NSTEMI was the final diagnosis in 15% (n = 412) of patients. QRS-T angles were significantly greater in patients with NSTEMI compared to those without (p < 0.001). The use of the QRS-T angle in addition to standard ECG criteria indicative of ischemia improved the diagnostic accuracy for NSTEMI as quantified by the area under the ROC curve from 0.68 to 0.72 (p < 0.001). An algorithm for the combined use of standard ECG criteria and the QRS-T angle improved the sensitivity of the ECG for NSTEMI from 45% to 78% and the specificity from 86% to 91% (p < 0.001 for both comparisons). The 2-year survival rates were 98%, 97% and 87% according to QRS-T angle tertiles (p < 0.001).
CONCLUSION: In patients with suspected NSTEMI, the QRS-T angle derived from the standard 12-lead ECG provides incremental diagnostic accuracy on top of standard ECG criteria indicative of ischemia, and independently predicts all-cause mortality during 2 years of follow-up.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30274750     DOI: 10.1016/j.ijcard.2018.09.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Novel ECG features and machine learning to optimize culprit lesion detection in patients with suspected acute coronary syndrome.

Authors:  Zeineb Bouzid; Ziad Faramand; Richard E Gregg; Stephanie Helman; Christian Martin-Gill; Samir Saba; Clifton Callaway; Ervin Sejdić; Salah Al-Zaiti
Journal:  J Electrocardiol       Date:  2021-07-23       Impact factor: 1.438

2.  Diagnostic and prognostic values of the QRS-T angle in patients with suspected acute decompensated heart failure.

Authors:  Romy Sweda; Zaid Sabti; Ivo Strebel; Nikola Kozhuharov; Desiree Wussler; Samyut Shrestha; Dayana Flores; Patrick Badertscher; Pedro Lopez-Ayala; Tobias Zimmermann; Eleni Michou; Danielle M Gualandro; Andreas Häberlin; Hildegard Tanner; Dagmar I Keller; Albina Nowak; Otmar Pfister; Tobias Breidthardt; Christian Mueller; Tobias Reichlin
Journal:  ESC Heart Fail       Date:  2020-05-26

3.  In Search of an Optimal Subset of ECG Features to Augment the Diagnosis of Acute Coronary Syndrome at the Emergency Department.

Authors:  Zeineb Bouzid; Ziad Faramand; Richard E Gregg; Stephanie O Frisch; Christian Martin-Gill; Samir Saba; Clifton Callaway; Ervin Sejdić; Salah Al-Zaiti
Journal:  J Am Heart Assoc       Date:  2021-01-17       Impact factor: 5.501

4.  QRS-T-angle in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) - a Comparison with Cardiac Magnetic Resonance Imaging.

Authors:  B Zadeh; J M Wambach; M Lambers; K Nassenstein; C J Jensen; O Bruder
Journal:  Int J Med Sci       Date:  2020-08-25       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.